INTRODUCTIONMelanoma constitutes 3% of all skin cancers, but accounts for 65% of skin cancer deaths.1 The incidence of melanoma is increasing, with approximately 100,000 new diagnoses annually, of which more…
Read More
INTRODUCTIONMelanoma is the fifth most common cancer in men and women in the United States (US), with an estimated 97,610 new cases in the year 2023.1 Although it accounts for…
Read More
INTRODUCTIONPostinflammatory hyperpigmentation (PIH) is an acquired increase in melanin in response to inflammation or injury, including surgical intervention.1,2 PIH has been shown to have a significant impact on quality of…
Read More
INTRODUCTIONSkin cancer is one of the most common malignancies in humans.1 There are 3 main categories of skin cancer, derived from the cell from which these cancers arise: basal cell…
Read More
INTRODUCTIONMentorship is a key factor for dermatology residency match success.1 However, dermatology mentor demand grossly exceeds supply, especially for dermatology residency applicants who are underrepresented in medicine (UIM) and/or without…
Read More
INTRODUCTIONMedical student-run free clinics (SRFC) are prevalent in medical schools, with 208 sites reported from 84 institutions in 2014.1 SRFCs historically emphasize primary care services and serve under-resourced populations. Data…
Read More
INTRODUCTIONHidradenitis suppurativa (HS) is a chronic inflammatory disease that causes painful, foul-smelling, and movement-restricting lesions in intertriginous regions. One of the primary therapies for HS and one of the two…
Read More
INTRODUCTIONSkin self-examinations (SSE) are an integral part of skin cancer surveillance, with the potential to reduce mortality from melanoma by 63%.1 Many patients rely on information found online, e.g. Google,…
Read More
INTRODUCTIONSkin self-examination (SSE) has been correlated with early detection of skin cancers; in one study over half of melanoma cases were self-recognized prior to diagnosis.1 Patients often reference photos from…
Read More
INTRODUCTIONHydroxychloroquine (HCQ) is a 4-aminoquinoline used to treat malaria and as a disease-modifying agent in rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE).1 Side effects associated with using HCQ include…
Read More
INTRODUCTIONWound repair in particular areas of the body presents treatment challenges. Epidermal fragility, inflamed margins, and heightened skin tension secondary to suturing, increase the risk of wound dehiscence and delay…
Read More
INTRODUCTIONMerkel cell carcinoma (MCC) is a rare, highly aggressive skin malignancy, with an incidence of 0.7/100,000 person-years in the United States in 2013.1 The development of MCC is associated with…
Read More
